NASD · Communication Services · Advertising Agencies · China
Haoxi Health Technology Ltd is a micro cap company (market value under $300 million) in the Advertising Agencies industry.
Intrinsic value, DCF valuation, financial health and value investing analysis for the Haoxi Health Technology Ltd stock.
No reliable verdict: intrinsic value $34.00 per share, market price $1.92 (as of 2026-10-30).
Its earnings through the cycle, capitalised at its cost of capital, would put the shares at $34.00: 18 times the price of $1.92. A gap that size says more about a model than about the market. It usually means heavy debt, where a small error in the value of the business becomes a large one in the value of the shares, or a business our method does not describe. We do not publish a verdict on this one.
All 37 Advertising Agencies stocks
We do not publish a verdict on HAO. Its earnings through the cycle, capitalised at its cost of capital, would put the shares at $34.00: 18 times the price of $1.92. A gap that size says more about a model than about the market. It usually means heavy debt, where a small error in the value of the business becomes a large one in the value of the shares, or a business our method does not describe. We do not publish a verdict on this one.
We do not publish one (as of the 2026-10-30 close). Its earnings through the cycle, capitalised at its cost of capital, would put the shares at $34.00: 18 times the price of $1.92. A gap that size says more about a model than about the market. It usually means heavy debt, where a small error in the value of the business becomes a large one in the value of the shares, or a business our method does not describe. We do not publish a verdict on this one.